Optimal treatment strategy after first-line induction therapy in advanced HER2-positive oeso-gastric adenocarcinoma—a retrospective, international, multicentric AGEO study
暂无分享，去创建一个
G. Prager | R. Guimbaud | L. Mineur | J. Taieb | F. Pietrantonio | D. Tougeron | G. Aprile | P. Artru | M. Ben Abdelghani | L. Pilla | A. Zaanan | A. Ilhan-Mutlu | M. Antista | E. Auclin | M. Mabro | V. Hautefeuille | Gaël S. Roth | E. Bergen | R. Longarini | A. Drouillard | D. Basile | C. Toullec | F. Ghelardi | Filippo Ghelardi | Inès Clement